Agenus Inc. (AGEN)
NASDAQ·Healthcare·Biotechnology
$2.97
-0.50%
Mkt Cap $134.09M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$7.33
Range $7.00 – $8.00
Implied Upside
+147.2%
Consensus $7.33 vs current $2.97
NASDAQ·Healthcare·Biotechnology
$2.97
-0.50%
Mkt Cap $134.09M
No recent rating data.
Price Target (5 analysts)
$7.33
Range $7.00 – $8.00
+147.2%
Consensus $7.33 vs current $2.97